U.S., June 19 -- ClinicalTrials.gov registry received information related to the study (NCT07657273) titled 'Yttrium-90 Carbon Microsphere Radioembolization in Previously Treated Hepatocellular Carcinoma' on June 15.
Brief Summary: This is a prospective, open-label, single-arm, investigator-initiated study designed to evaluate the safety and efficacy of NRT6003 Injection, a yttrium-90 carbon microsphere product, administered by selective internal radiation therapy in previously treated patients with hepatocellular carcinoma.
Eligible participants will undergo protocol-specified screening assessments, hepatic vascular evaluation, 99mTc-MAA hepatic arterial perfusion imaging, and dosimetry assessment before treatment. Participants who meet ...